Compositions and methods in cancer associated with altered expression of KCNJ9
US7700274B2 · kind B2 · utility
0Cited by
42References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2002 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | May 4, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.